Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
SMS Pharmaceuticals Limited (NSE: SMSPHARMA), ISIN INE812G01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SMSPHARMA last traded at ₹481.05 (-0.36%), with a 52-week range of ₹240.45 to ₹494.40 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 68.07%, FIIs 0.65%, DIIs 2.83%, mutual funds 2.81%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.